Clinical trial
FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019
NCT04517396 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 18, 2020
- Completion date
- March 30, 2022
- Enrollment
- 701 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19